Drugs / INH
last change Jan 2014 re-read 2 minutes ago

INH

Developed for
type 2 diabetes mellitus
Investigated by
Dance Biopharm Inc.

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02716610 Oct 2013 → Jan 2014 type 2 diabetes mellitus Dance Biopharm Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as INH ClinicalTrials.gov intervention name — accepted as the source's own label NCT02716610
Route Inhaled inhaled human insulin” NCT02716610